Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 159473

Sabadell, Barcelona 08208

0 studies enrolling now · 1 studies all time

What they study most

Ulcerative Colitis (UC)

Studies at this site

• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis — Running, not enrolling